1-6 of 6
Salvatore Buffardi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Auke Beishuizen, Luciana Vinti, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Franca Fagioli, Constantino Sabado Alvarez, Stephane Ducassou, Salvatore Buffardi, Maitane Andión Catalan, Brad Hoppe, Frank Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Stephen Daw
Journal: Blood
Blood (2023) 142 (Supplement 1): 3063.
https://doi.org/10.1182/blood-2023-187028
Published: 2023
Journal Articles

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults

Clinical Trials & Observations
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, Maurizio Mascarin, Gérard Michel, Stacy Cooper, Auke Beishuizen, Kasey J. Leger, Loredana Amoroso, Salvatore Buffardi, Charlotte Rigaud, Bradford S. Hoppe, Julie Lisano, Stephen Francis, Mariana Sacchi, Peter D. Cole, Richard A. Drachtman, Kara M. Kelly, Stephen Daw
Journal: Blood
Blood (2023) 141 (17): 2075–2084.
https://doi.org/10.1182/blood.2022017118
Published: 2023
Includes: Supplemental data
Journal Articles

Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma

Paul Harker-Murray, MD PhD, Thierry Leblanc, MD, Maurizio Mascarin, Christine Mauz-Körholz, Gerard Michel, MD, Stacy Cooper, MD, Auke Beishuizen, MD PhD, Kasey J. Leger, MD MSc, Alberto Garaventa, Salvatore Buffardi, MD, Laurence Brugieres, MD, Kara M. Kelly, MD, Peter D. Cole, MD, Richard A. Drachtman, Faith Galderisi, DO, Mariana Sacchi, MD, Ying-Ming Jou, Stephen Daw
Journal: Blood
Blood (2018) 132 (Supplement 1): 927.
https://doi.org/10.1182/blood-2018-99-111279
Published: 2018
Journal Articles

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giuseppe Menna, MD, Giovanni Cazzaniga, PhD, Giada Muccioli Casadei, PhD, Salvatore Buffardi, MD, Giovanna Maisto, Rosanna Parasole, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5045.
https://doi.org/10.1182/blood.V130.Suppl_1.5045.5045
Published: 2017
Journal Articles

Brentuximab Vedotin in Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults

Luciana Vinti, MD, Franco Locatelli, MD PhD, Pietro Merli, MD, Rosanna Parasole, MD, Salvatore Buffardi, MD, Marta Pillon, Luisa Strocchio, Katia Girardi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4090.
https://doi.org/10.1182/blood.V130.Suppl_1.4090.4090
Published: 2017
Journal Articles

Minimal Disseminated Disease Is An Independent Poor Prognosis Marker Among High Risk Burkitt's Lymphoma Patients .

Lara Mussolin, Marta Pillon, Gloria Tridello, Maria Paola Boaro, Emanuele S d'Amore, Luca Lo Nigro, Salvatore Buffardi, Alessandra Lombardi, Alessandra Sala, Claudio Favre, Maurizio Aricò, Angelo Rosolen
Journal: Blood
Blood (2009) 114 (22): 2944.
https://doi.org/10.1182/blood.V114.22.2944.2944
Published: 2009